Estrogen action via the G protein-coupled receptor, GPR30: Stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis

Molecular Endocrinology

Volumn 16, Issue 1, 2002, Pages 70-84

  Filardo, Edward J ^a,b,c   Quinn, Jeffrey A ^a,b   Raymond Frackelton Jr , A ^b   Bland, Kirby I ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; 4 HYDROXYTAMOXIFEN; ADENYLATE CYCLASE; ANTIESTROGEN; CYCLIC AMP; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; RECOMBINANT EPIDERMAL GROWTH FACTOR; TAMOXIFEN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL STRAIN MCF 7; ENZYME ACTIVATION; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036140032     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.1.0758     Document Type: Article

References (68)

1. Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
2. Mammalian MAP kinase signalling cascades
3. New insights into the control of MAP kinase pathways
4. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
5. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
6. Specificity of receptor tyrosine kinase signaling: Transient vs. sustained extracellular signal-regulated kinase activation
7. Regulation of cell motility by mitogen-activated protein kinase
8. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
9. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling
10. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: Consequence on DNA binding
11. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
12. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
13. Rapid activation of MAP kinase by estrogen in the bone cell line
14. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription
15. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
16. Hyperexpression of mitogen-activated protein kinase in human breast cancer
17. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
18. Gβγ-subunits mediate src-dependent phosphorylation of the epidermal growth factor receptor
19. c-Src-mediated phosphorylation of the EGF receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function
20. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
21. Integrins induce activation of EGF receptor: Role in MAP kinase induction and adhesion-dependent cell survival
22. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
23. Estrogen-induced activation of Erk-1 and Erk-2 requires the G-protein coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF
24. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
25. Estradiol causes the rapid accumulation of cAMP in human prostate
26. Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin
27. Inhibition by cAMP of Ras-dependent activation of Raf
28. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′, 5′-monophosphate
29. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway
30. Complexity and diversity of mammalian adenylyl cyclases
31. Structural basis of G protein-coupled receptor function
32. Androgen and estrogen signaling at the cell membrane via G proteins and cyclic adenosine monophosphate
33. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells
34. Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor alpha
35. Estrogen receptors α and β: Two receptors of a kind?
36. Expression and regulation of estrogen receptor β in human breast tumors and cell lines
37. Expression of estrogen receptor-β in human breast tumors
38. Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP
39. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases
40. Diphtheria toxin receptor: Identification of specific diphtheria toxin-binding proteins on the surface of Vero and BS-C-1 cells
41. Steroid hormone receptors: Many actors in search of a plot
42. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3′,5′-monophosphate
43. Cell signaling and estrogens in female rat osteoblasts: A possible involvement of unconventional non-nuclear receptors
44. Nongenomic effects of 17 β-estradiol on maturing human oocytes: Relationship to oocyte development potential
45. Estradiol signaling via sequestrable surface receptors
46. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein
47. Progesterone triggers rapid transmembrane calcium influx and/or calcium mobilization from endoplasmic reticulum, via a pertussis-insensitive G-protein in granulosa cells in relation to luteinization process
48. 2+-fluxes in sperm
49. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages
50. Dual effect of β-adrenergic receptors on mitogen-activated protein kinase. Evidence for a βγ-dependent activation and a Gαs-cAMP-mediated inhibition
51. The endometrial effects of SERMs
52. Intrauterine injection of cholera toxin induces estrogen-like uterine growth
53. Sex hormone-binding globulin receptor signal transduction proceeds via a G protein
54. Elevation of cyclic adenosine 3′, 5′ monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cells
55. Identification of the major phosphorylation sites of the Raf-1 kinase
56. Mechanism of inhibition of raf-1 by protein kinase A
57. Negative regulation of Raf-1 by phosphorylation of serine 621
58. Phosphorylation of serine 43 is not required for inhibition of c-Raf kinase by the cAMP-dependent protein kinase
59. β2-adrenergic receptor activates extracellular signal-regulated kinases (erks) via the small G-protein Rap1 and the serine/threonine kinase B-Raf
60. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol
61. Regulation of epidermal growth factor receptor by estrogen
62. Differential expression of epidermal growth factor receptor (EGF-R) gene and regulation of EGF-R bioactivity by progesterone and estrogen in the adult mouse uterus
63. Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells
64. Growth response of breast epithelial cells to estrogen is influenced by EGF
65. Oestrogen and progesterone inhibit the stimulated production of endothelin-1
66. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
67. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the Pl3-kinase-Akt pathway in human endothelial cells
68. Aberrant function of the Ras signal transduction pathway in human breast cancer